Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome.

Avagliano Trezza R
Sonzogni M
Bossuyt SNV
Zampeta FI
Punt AM
van den Berg M
Rotaru DC
Koene LMC
Munshi ST
Stedehouder J
Kros JM
Williams M
Heussler H
de Vrij FMS
Mientjes EJ
van Woerden GM
Kushner SA
Distel B
Elgersma Y
Scientific Abstract

Mutations affecting the gene encoding the ubiquitin ligase UBE3A cause Angelman syndrome. Although most studies focus on the synaptic function of UBE3A, we show that UBE3A is highly enriched in the nucleus of mouse and human neurons. We found that the two major isoforms of UBE3A exhibit highly distinct nuclear versus cytoplasmic subcellular localization. Both isoforms undergo nuclear import through direct binding to PSMD4 (also known as S5A or RPN10), but the amino terminus of the cytoplasmic isoform prevents nuclear retention. Mice lacking the nuclear UBE3A isoform recapitulate the behavioral and electrophysiological phenotypes of Ube3a mice, whereas mice harboring a targeted deletion of the cytosolic isoform are unaffected. Finally, we identified Angelman syndrome-associated UBE3A missense mutations that interfere with either nuclear targeting or nuclear retention of UBE3A. Taken together, our findings elucidate the mechanisms underlying the subcellular localization of UBE3A, and indicate that the nuclear UBE3A isoform is the most critical for the pathophysiology of Angelman syndrome.

Citation
2019. Nat Neurosci, 22(8):1235-1247.
DOI
10.1038/s41593-019-0425-0
Related Content
Publication
Beudel M, Little S, Pogosyan A, Ashkan K, Foltynie T, Limousin P, Zrinzo L, Hariz M, Bogdanovic M, Cheeran B, Green AL, Aziz TZ, Thevathasan W, Brown P
2015.Neuromodulation, 18(5):349-54.
Publication
Patai EZ, Foltynie T, Limousin P, Akram H, Zrinzo L, Bogacz R, Litvak V

2022. J Neurosci, 42(23):4681-4692.

Publication
Moeller M, Grohn J, Manohar S, Bogacz R

2021. PLoS Comput Biol, 17(7)e1009213.

Publication
Barron HC, Reeve HM, Koolschijn RS, Perestenko PV, Shpektor A, Nili H, Rothaermel R, Campo-Urriza N, O'Reilly JX, Bannerman DM, Behrens TE, Dupret D
2020. Cell, 183(1):228-243.e21.
Publication
Sloan M, Alegre-Abarrategui J, Potgieter D, Kaufmann AK, Exley R, Deltheil T, Threlfell S, Connor-Robson N, Brimblecombe KR, Wallings R, Cioroch M, Bannerman DM, Bolam JP, Magill PJ, Cragg SJ, Dodson PD, Wade-Martins R
2016.Hum. Mol. Genet., 25(5):951-63.